12th March 2020

Tecrea announce exclusive global animal healthcare partnership

Tecrea Ltd has entered into a multi-million-pound global deal with a top 10 animal healthcare company to develop new animal health medicines using Tecreaʼs innovative nanotechnology.

Tecreaʼs platform has the potential to enhance both new and old medicines for the treatment of many conditions across human and animal health. The partner company will be using the technology to create new medicines specifically within the animal health sectors.

John Ridden, Tecrea CEO, says of the deal “We are excited to be working on this substantial partnership with one of the worldʼs leading animal health companies, to bring new drugs to market. This partnership allows for true medicines innovation in the field of animal health and we are delighted to be part of it.”

Jonathan Elliott, Vice Principal for Research & Innovation at the Royal Veterinary College says ʻit is hugely satisfying to see technology based on new knowledge, generated at the RVC, taking the next step on the path towards significant impact. We are excited at the very real prospect, that over the coming years, we will see product development based on our discoveries benefiting the health and welfare of animals and the livelihoods of people throughout the worldʼ

The Partnered global animal health company develops products and knowledge services to prevent and treat disease in food animals and pets in more than 90 countries. With a long heritage, they rigorously innovate to improve the health of animals and benefit customers, while fostering an inclusive, cause-driven culture.

Tecrea Ltd was founded in 2012 as a spin-out of the Royal Veterinary College, University of London, to empower researchers working in the life science and drug development field through innovation in nanotechnology. Tecrea have developed the technology to create a unique range of cell and tissue delivery tools that are fully translatable from the lab to the clinic, with progress in human and animal health being made through strategic partnerships. More information can be found at